Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Ward

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Current Opinion in Genetics & Development|April 3, 2010
Epimutations and cancer predisposition: importance and mechanismsLuke B Hesson, Megan P Hitchins, Robyn L Ward
Journal of Community Genetics|September 27, 2021
Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessmentsSarah Norris, Andrea Belcher, Kirsten Howard, et al.
Pathology|January 18, 2011
Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinomaSian C Hicks, Robyn L Ward, Nicholas J Hawkins
Public Health Research & Practice|May 3, 2019
Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012Carole Harris, Benjamin Daniels, Robyn L Ward, et al.
International Journal of Cancer|February 6, 2003
Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signallingYum L Yip, Jiri Novotny, Michael Edwards, et al.
International Journal of Technology Assessment in Health Care|September 15, 2016
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALSChris Henshall, Nicholas R Latimer, Lloyd Sansom, et al.
Analytical Biochemistry|January 4, 2011
Quantitative analysis of tissue folate using ultra high-performance liquid chromatography tandem mass spectrometryJia Liu, Russell Pickford, Alan P Meagher, et al.
Nature Genetics|April 6, 2004
Germline epimutation of MLH1 in individuals with multiple cancersCatherine M Suter, David I K Martin, Robyn L Ward
International Journal of Cancer|December 13, 2012
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesisCaroline E Ford, Sean Si Qian Ma, Ashfaque Quadir, et al.
Pathology|August 23, 2002
C-kit mutations in gastrointestinal stromal tumoursAdrienne L Morey, G David Wanigesekera, Nicholas J Hawkins, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Current Opinion in Genetics & Development|April 3, 2010
Epimutations and cancer predisposition: importance and mechanismsLuke B Hesson, Megan P Hitchins, Robyn L Ward
Journal of Community Genetics|September 27, 2021
Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessmentsSarah Norris, Andrea Belcher, Kirsten Howard, et al.
Pathology|January 18, 2011
Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinomaSian C Hicks, Robyn L Ward, Nicholas J Hawkins
Public Health Research & Practice|May 3, 2019
Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012Carole Harris, Benjamin Daniels, Robyn L Ward, et al.
International Journal of Cancer|February 6, 2003
Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signallingYum L Yip, Jiri Novotny, Michael Edwards, et al.
International Journal of Technology Assessment in Health Care|September 15, 2016
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALSChris Henshall, Nicholas R Latimer, Lloyd Sansom, et al.
Analytical Biochemistry|January 4, 2011
Quantitative analysis of tissue folate using ultra high-performance liquid chromatography tandem mass spectrometryJia Liu, Russell Pickford, Alan P Meagher, et al.
Nature Genetics|April 6, 2004
Germline epimutation of MLH1 in individuals with multiple cancersCatherine M Suter, David I K Martin, Robyn L Ward
International Journal of Cancer|December 13, 2012
The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesisCaroline E Ford, Sean Si Qian Ma, Ashfaque Quadir, et al.
Pathology|August 23, 2002
C-kit mutations in gastrointestinal stromal tumoursAdrienne L Morey, G David Wanigesekera, Nicholas J Hawkins, et al.
Pageof 16